Abstract. Calcium phosphate ceramics like hydroxyapatite (HA) are widely used to repair and reconstruct damaged parts of the human skeleton. This material is currently available as injectable cements, granules or macroporous blocks. The most familiar materials are granule shaped ones because their conveniency to be implanted in human body. In this study, a new manufacturing procedure to fabricate dense, microporous and macroporous hydroxyapatite spherical granules based on a lost wax principle and allowing the fabrication of beads with a fully controlled porosity is presented. The HA granules porous structure is used to impregnation by gentamicine and other active substances. The drug and phage releasing kinetics are compared as a function of time and ceramic porosity.
INTRODUCTION
Bioceramic materials as calcium phosphate ceramics and in particular hydroxyapatite (HA) and tricalcium phosphate β (β-TCP) because of their excellent biocompatibility, bioactivity and osteoconduction properties are widely used to repair and reconstruct damaged parts of the human skeleton and especially as bone substitutes in the filling of bone defects [1] . These materials are available in the form of injectable cements, granules or macroporous blocks. Calcium phosphate granules have been generally selected for classical bone filling [2] . However, these granules present irregular shapes and do not allow for optimal filling of bone cavity or defect. To overcome this problem, adjunction of a binding agent such as fibrin glue can stabilize the granules in the implantation site and produce a composite that can be moulded into the defect without empty spaces [3] .
Many processing routes have been used for fabrication of porous hydroxyapatite granules, such as hydrothermal conversion of natural corals [4] , crushing of sintered blocks, granulation by vibration and rolling [5] , dripping procedure, casting in plaster mould, emulsion methods [6] , spray-drying process. However, these processes do not yield granules with optimal properties for medical applications. A last method similar to the lost wax process consists in building a calcium carbonate scaffold around a model part constituted of piled up calibrated PMMA balls. After thermal treatment, the ball debinding resulting empty space is filled by HA powder aqueous slurry. After carbonate scaffold elimination, controlled size and shape HA beads are obtained [7] .
Besides their use as bone filling material, these HA beads if presenting any microporosity could be used in the orthopedic field as drug delivery carriers, such as growth factors, anticancer drugs, antibiotic agents. . . Among these products, the gentamicin antibiotic is frequently used for its prophylactic action. Another type of substances like phages used for phagotherapy in case of nosocomial diseases can also be incorporated in porous beads.
In this study, we present the fabrication process for dense, micro and macro-porous HA beads from lost wax process and comparative results of drug loading and release rate in the microporous HA beads with gentamicin antibiotic and lambda phage EXPERIMENTAL HA powder synthesis HA powder was prepared by aqueous precipitation technique using a diammonium phosphate solution and a calcium nitrate solution. Details of the procedure have been published elsewhere [8] . After successive steps of precipitation-calcination-milling, the as-obtained powder presents a surface area of 5 m2/g, mean particle size of 1 µm, Ca/P ratio of 1.66, high purity verified by transparency of hot isostatic pressed samples. A complete densification is achieved by pressureless sintering after 3 hours at 1250
• C [8] .
Fabrication of ceramic beads
The porous ceramic beads are fabricated through the lost wax process. The first step is to elaborate a model part in organic balls, to infiltrate it by calcium carbonate slurry and to burn the organic species by thermal treatment. The as-resulting voids are filled with HA powder slurry and the carbonate surrounding carapace is destroyed by higher thermal treatment.
a) Preparation of the organic skeleton
An organic skeleton is built by stacking PMMA balls (Diakon TM Ineos Acrylics Holland, Saluc Belgium) with diameters in the range of 100 micrometres to 3 millimetres. The bridging between polymeric balls is obtained by a MATEC Web of Conferences chemical treatment using acetone (RPE 99.8% Carlo Erba, France) which exhibits a dissolution chemical action with respect to the PMMA and induces an overlapping between the individual bodies (Fig. 1a) .
b) Preparation of calcium carbonate scaffold
The as-prepared organic skeleton is then impregnated by the calcium carbonate suspension in order to fill voids between polymeric PMMA balls. CaCO3 powder (Mikhart 2, Provençale s.a, France) presents a surface area of 3.3 m2/g, mean particle size of 3 µm and a purity level superior to 99%. CaCO3 aqueous slurry was prepared with 64 wt % dry matter. Slurry defloculation is assured by Darvan C ( R.t.Vanderbilt.Co) in amount equal to 1.5 wt. % of CaCO3 content. A quantity of organic binder (4 wt. % of CaCO3 content, Duramax B1001, Rohm and Haas) was added to ensure a consolidation of green material during the debinding treatment. Slip preparation is carried out using a planetary ball mill with agate container and balls. Milling duration is fixed to 1 hour with a rotation speed equal to 180 revolutions per minute. After infiltration process (Fig 1a') , the sample is dried in a plaster mould and debound by heating to 220
• C during 20 hours followed by a dwell at 250
• C for 10 hours. The elimination of PMMA balls creates a controlled size macroporosity within the ceramic. After debinding, the 3% residual organic ensures a sufficient mechanical strength for the handling of samples during the later stages and the sample is constituted of macropores with a size equal to the size of the used PMMA balls. These cavities are interconnected. Figures 1a' represent a macroscopic and microscopic views of CaCO3 impregnated organic skeleton. The calcium carbonate scaffold after debinding is presented in Fig. 1b. 
c) Manufacturing of dense or microporous HA beads
HA aqueous slurry was prepared under the same experimental conditions than CaCO3 suspension. Powder concentration was equal to 75 wt. % and dispersion powder was assured by Darvan C in amount equal to 1.5 wt.% of HA content. Calcium carbonate scaffold is impregnated by aqueous suspensions of hydroxyapatite in order to fill cavities left by the PMMA balls. This operation is performed into a plaster mould in order to allow the drying of the part. Figure 1c represents a macroscopic view of polished CaCO3 scaffold filled with hydroxyapatite after drying. After filling CaCO3 scaffold by the hydroxyapatite powder, the material is heated up to 1000
• C to transform the calcium carbonate to lime and to induce a pre-sintering of HA powder and a consolidation of the ceramic balls in order to resist during the demolition of calcium carbonate scaffold.
During cooling, the samples undergo a water quenching from 200
• C to transform lime into calcium hydroxide. This reaction is accompanied by a significant swelling of the structure causing the CaCO3 ceramic disintegration and the HA beads releasing. After this step, HA balls and Ca(OH)2 powder are separated by mechanical sieving.
Figures 1d represent a macroscopic view of HA beads obtained using CaCO3 scaffold made from various PMMA balls diameters in the range of 100 micrometres to 3 millimetres calibrated balls.
In order to obtain different porosity ranges, beads are sintered at different temperatures: 1275, 1150 and 1100
• C. Sintering at the highest temperature makes it possible to obtain 97.5% as relative density. On contrary, the lowest temperatures (1150 and 1100
• C) offer porous beads characterized by an micronic open porosity volume equal to 20 and 42% respectively.
BIOLOGICAL FUNCTIONALIZATION
Bacterial strain, phage, media and growth conditions.
The bacterium used in this study is Escherichia coli K12 strain (A324). This bacterium is lytic λ phage sensitive. The bacterium was grown at 150 rpm and incubated at 37
• C, in agitation 170 rpm in Luria-Bertani broth (LB: bactotrypton at 5 g/l, yeast extracts at 10 g/L, NaCl at 5 g/l and pH 7.2). Solid media used is the Rmedium (added agar at 15 g/L).
Phage λ vir used as antibacterial loading agents is a lytic phage and conserves all virulence properties.
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The λvir stock was prepared by infecting Escherichia coli K12 strain (A324). All the HA samples corresponding to different sintering conditions were incubated for 24 h with 5 ml of stock λ phage. After incubation, the sample was washed once with LB medium to remove excess phage suspension.
Cultures of 30 ml of Escherichia coli K12 (A324) in LB liquid medium were performed for each condition. The growth of E. coli was performed at 37
• C with agitation at 170 rpm. To measure bacterial growth, optical density of about 0,12 at 620 nm was followed. The λ phageloaded HA samples were introduced into culture tubes after obtaining a growth of two generations. Growth was followed until complete lysis of bacteria. Figure 2 shows the efficiency of bacterial lysis λ phageloaded HA samples according to their microporosity (depending on sintering temperature). As shown on the graph, the phage impregnated ceramic parts are introduced in the bacterial medium after about 90 minutes (after development of 2 bacterial generations). We can notice that the lyse of bacteria takes place after about 90 minutes all the more quickly as the microporosity of the ceramic is high. For all samples, a total bacterial destruction is noticed after 1 more hour. It is interesting to note that the dense HA sample (sintered at 1275
RESULTS AND DISCUSSION
• C) presents also an antibacterial effect which indicates a strong interaction between bacteriophage lambda with the HA ceramic surface.
CONCLUSIONS
These first experiments reveal that microporous HA microspheres can be used as a matrix for local drug delivery system to prevent and curate infections associated to bone implants. The drug release quantity and duration can be controlled by the morphology and microstructure of HA beads and in particular by the porous volume in order to obtain drug delivery system according with the therapeutic dosage.
